Group-based Sleep Treatment with Cognitive Behavioral Therapy and Optional Blue-Blocking Glasses for Adults with Insomnia and Psychiatric Disorders

What this Trial Is About

Sleep disorders, particularly insomnia, often occur alongside psychiatric conditions. Researchers are studying the effects of a non-drug, group-based treatment called cognitive behavioral therapy for insomnia CBTi on sleep and psychiatric symptoms. They aim to fill the knowledge gap about how to best treat sleep problems within psychiatric care. CBTi includes sleep education, restricting time in bed, controlling stimuli related to sleep, and changing unhelpful thoughts about sleep. Participants are randomized into one of three groups one receiving usual psychiatric care plus group-based CBTi, another receiving the same plus wearing blue-blocking glasses before bedtime, and a third group placed on an 8-week waitlist continuing usual care. The group sessions occur every other Monday for about two hours. All participants have an initial consultation including eligibility assessment, diagnostic evaluation, and sleep hygiene education. Follow-up occurs 12 months after treatment. Throughout the study, participants undergo assessments of insomnia symptoms at baseline, bi-weekly during treatment, after 8 weeks, and at 12 months follow-up. Researchers measure various sleep parameters such as time in bed, sleep efficiency, total sleep time, and early morning awakening. They also monitor changes in depression, anxiety, fatigue, work status, and general well-being. Treatment adherence and safety are observed as part of the study.

Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia